The global Sofosbuvir (CAS 1190307-88-0) market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2022 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Teva Pharmaceutical Industries Ltd
Beijing Kawin Technology Share-holding Co
DEAFARMA
DONG BANG FUTURE TECH & LIFE CO., LTD
Shanghai Haoyuan Chemexpress Co., Ltd
Beaukev Pharma International Pvt.Ltd
Anhui HaiKang Pharmaceutical Co. Ltd
Tecoland
Hangzhou Longshine Bio-Tech Co
By Types:
Purity ≥ 98%
Purity ＜ 98%
By Applications:
Adults Patients
Elderly Patients
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Sofosbuvir (CAS 1190307-88-0) Market Size Analysis from 2022 to 2027
1.5.1 Global Sofosbuvir (CAS 1190307-88-0) Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Sofosbuvir (CAS 1190307-88-0) Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Sofosbuvir (CAS 1190307-88-0) Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Sofosbuvir (CAS 1190307-88-0) Industry Impact
Chapter 2 Global Sofosbuvir (CAS 1190307-88-0) Competition by Types, Applications, and Top Regions and Countries
2.1 Global Sofosbuvir (CAS 1190307-88-0) (Volume and Value) by Type
2.1.1 Global Sofosbuvir (CAS 1190307-88-0) Consumption and Market Share by Type (2016-2021)
2.1.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue and Market Share by Type (2016-2021)
2.2 Global Sofosbuvir (CAS 1190307-88-0) (Volume and Value) by Application
2.2.1 Global Sofosbuvir (CAS 1190307-88-0) Consumption and Market Share by Application (2016-2021)
2.2.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue and Market Share by Application (2016-2021)
2.3 Global Sofosbuvir (CAS 1190307-88-0) (Volume and Value) by Regions
2.3.1 Global Sofosbuvir (CAS 1190307-88-0) Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Sofosbuvir (CAS 1190307-88-0) Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Sofosbuvir (CAS 1190307-88-0) Consumption by Regions (2016-2021)
4.2 North America Sofosbuvir (CAS 1190307-88-0) Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Sofosbuvir (CAS 1190307-88-0) Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Sofosbuvir (CAS 1190307-88-0) Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Sofosbuvir (CAS 1190307-88-0) Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Sofosbuvir (CAS 1190307-88-0) Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Sofosbuvir (CAS 1190307-88-0) Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Sofosbuvir (CAS 1190307-88-0) Sales, Consumption, Export, Import (2016-2021)
4.10 South America Sofosbuvir (CAS 1190307-88-0) Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Sofosbuvir (CAS 1190307-88-0) Market Analysis
5.1 North America Sofosbuvir (CAS 1190307-88-0) Consumption and Value Analysis
5.1.1 North America Sofosbuvir (CAS 1190307-88-0) Market Under COVID-19
5.2 North America Sofosbuvir (CAS 1190307-88-0) Consumption Volume by Types
5.3 North America Sofosbuvir (CAS 1190307-88-0) Consumption Structure by Application
5.4 North America Sofosbuvir (CAS 1190307-88-0) Consumption by Top Countries
5.4.1 United States Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
5.4.2 Canada Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
5.4.3 Mexico Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
Chapter 6 East Asia Sofosbuvir (CAS 1190307-88-0) Market Analysis
6.1 East Asia Sofosbuvir (CAS 1190307-88-0) Consumption and Value Analysis
6.1.1 East Asia Sofosbuvir (CAS 1190307-88-0) Market Under COVID-19
6.2 East Asia Sofosbuvir (CAS 1190307-88-0) Consumption Volume by Types
6.3 East Asia Sofosbuvir (CAS 1190307-88-0) Consumption Structure by Application
6.4 East Asia Sofosbuvir (CAS 1190307-88-0) Consumption by Top Countries
6.4.1 China Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
6.4.2 Japan Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
6.4.3 South Korea Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
Chapter 7 Europe Sofosbuvir (CAS 1190307-88-0) Market Analysis
7.1 Europe Sofosbuvir (CAS 1190307-88-0) Consumption and Value Analysis
7.1.1 Europe Sofosbuvir (CAS 1190307-88-0) Market Under COVID-19
7.2 Europe Sofosbuvir (CAS 1190307-88-0) Consumption Volume by Types
7.3 Europe Sofosbuvir (CAS 1190307-88-0) Consumption Structure by Application
7.4 Europe Sofosbuvir (CAS 1190307-88-0) Consumption by Top Countries
7.4.1 Germany Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
7.4.2 UK Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
7.4.3 France Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
7.4.4 Italy Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
7.4.5 Russia Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
7.4.6 Spain Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
7.4.7 Netherlands Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
7.4.8 Switzerland Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
7.4.9 Poland Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
Chapter 8 South Asia Sofosbuvir (CAS 1190307-88-0) Market Analysis
8.1 South Asia Sofosbuvir (CAS 1190307-88-0) Consumption and Value Analysis
8.1.1 South Asia Sofosbuvir (CAS 1190307-88-0) Market Under COVID-19
8.2 South Asia Sofosbuvir (CAS 1190307-88-0) Consumption Volume by Types
8.3 South Asia Sofosbuvir (CAS 1190307-88-0) Consumption Structure by Application
8.4 South Asia Sofosbuvir (CAS 1190307-88-0) Consumption by Top Countries
8.4.1 India Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
8.4.2 Pakistan Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Market Analysis
9.1 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Consumption and Value Analysis
9.1.1 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Market Under COVID-19
9.2 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Consumption Volume by Types
9.3 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Consumption Structure by Application
9.4 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Consumption by Top Countries
9.4.1 Indonesia Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
9.4.2 Thailand Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
9.4.3 Singapore Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
9.4.4 Malaysia Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
9.4.5 Philippines Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
9.4.6 Vietnam Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
9.4.7 Myanmar Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
Chapter 10 Middle East Sofosbuvir (CAS 1190307-88-0) Market Analysis
10.1 Middle East Sofosbuvir (CAS 1190307-88-0) Consumption and Value Analysis
10.1.1 Middle East Sofosbuvir (CAS 1190307-88-0) Market Under COVID-19
10.2 Middle East Sofosbuvir (CAS 1190307-88-0) Consumption Volume by Types
10.3 Middle East Sofosbuvir (CAS 1190307-88-0) Consumption Structure by Application
10.4 Middle East Sofosbuvir (CAS 1190307-88-0) Consumption by Top Countries
10.4.1 Turkey Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
10.4.3 Iran Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
10.4.5 Israel Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
10.4.6 Iraq Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
10.4.7 Qatar Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
10.4.8 Kuwait Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
10.4.9 Oman Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
Chapter 11 Africa Sofosbuvir (CAS 1190307-88-0) Market Analysis
11.1 Africa Sofosbuvir (CAS 1190307-88-0) Consumption and Value Analysis
11.1.1 Africa Sofosbuvir (CAS 1190307-88-0) Market Under COVID-19
11.2 Africa Sofosbuvir (CAS 1190307-88-0) Consumption Volume by Types
11.3 Africa Sofosbuvir (CAS 1190307-88-0) Consumption Structure by Application
11.4 Africa Sofosbuvir (CAS 1190307-88-0) Consumption by Top Countries
11.4.1 Nigeria Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
11.4.2 South Africa Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
11.4.3 Egypt Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
11.4.4 Algeria Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
11.4.5 Morocco Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
Chapter 12 Oceania Sofosbuvir (CAS 1190307-88-0) Market Analysis
12.1 Oceania Sofosbuvir (CAS 1190307-88-0) Consumption and Value Analysis
12.2 Oceania Sofosbuvir (CAS 1190307-88-0) Consumption Volume by Types
12.3 Oceania Sofosbuvir (CAS 1190307-88-0) Consumption Structure by Application
12.4 Oceania Sofosbuvir (CAS 1190307-88-0) Consumption by Top Countries
12.4.1 Australia Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
12.4.2 New Zealand Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
Chapter 13 South America Sofosbuvir (CAS 1190307-88-0) Market Analysis
13.1 South America Sofosbuvir (CAS 1190307-88-0) Consumption and Value Analysis
13.1.1 South America Sofosbuvir (CAS 1190307-88-0) Market Under COVID-19
13.2 South America Sofosbuvir (CAS 1190307-88-0) Consumption Volume by Types
13.3 South America Sofosbuvir (CAS 1190307-88-0) Consumption Structure by Application
13.4 South America Sofosbuvir (CAS 1190307-88-0) Consumption Volume by Major Countries
13.4.1 Brazil Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
13.4.2 Argentina Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
13.4.3 Columbia Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
13.4.4 Chile Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
13.4.5 Venezuela Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
13.4.6 Peru Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
13.4.8 Ecuador Sofosbuvir (CAS 1190307-88-0) Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Sofosbuvir (CAS 1190307-88-0) Business
14.1 Teva Pharmaceutical Industries Ltd
14.1.1 Teva Pharmaceutical Industries Ltd Company Profile
14.1.2 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Product Specification
14.1.3 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Beijing Kawin Technology Share-holding Co
14.2.1 Beijing Kawin Technology Share-holding Co Company Profile
14.2.2 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Product Specification
14.2.3 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 DEAFARMA
14.3.1 DEAFARMA Company Profile
14.3.2 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Product Specification
14.3.3 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 DONG BANG FUTURE TECH & LIFE CO., LTD
14.4.1 DONG BANG FUTURE TECH & LIFE CO., LTD Company Profile
14.4.2 DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Product Specification
14.4.3 DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Shanghai Haoyuan Chemexpress Co., Ltd
14.5.1 Shanghai Haoyuan Chemexpress Co., Ltd Company Profile
14.5.2 Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Product Specification
14.5.3 Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Beaukev Pharma International Pvt.Ltd
14.6.1 Beaukev Pharma International Pvt.Ltd Company Profile
14.6.2 Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Product Specification
14.6.3 Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Anhui HaiKang Pharmaceutical Co. Ltd
14.7.1 Anhui HaiKang Pharmaceutical Co. Ltd Company Profile
14.7.2 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Product Specification
14.7.3 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Tecoland
14.8.1 Tecoland Company Profile
14.8.2 Tecoland Sofosbuvir (CAS 1190307-88-0) Product Specification
14.8.3 Tecoland Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Hangzhou Longshine Bio-Tech Co
14.9.1 Hangzhou Longshine Bio-Tech Co Company Profile
14.9.2 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Product Specification
14.9.3 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Sofosbuvir (CAS 1190307-88-0) Market Forecast (2022-2027)
15.1 Global Sofosbuvir (CAS 1190307-88-0) Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Sofosbuvir (CAS 1190307-88-0) Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Sofosbuvir (CAS 1190307-88-0) Value and Growth Rate Forecast (2022-2027)
15.2 Global Sofosbuvir (CAS 1190307-88-0) Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Sofosbuvir (CAS 1190307-88-0) Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Sofosbuvir (CAS 1190307-88-0) Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Sofosbuvir (CAS 1190307-88-0) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Sofosbuvir (CAS 1190307-88-0) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Sofosbuvir (CAS 1190307-88-0) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Sofosbuvir (CAS 1190307-88-0) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Sofosbuvir (CAS 1190307-88-0) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Sofosbuvir (CAS 1190307-88-0) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Sofosbuvir (CAS 1190307-88-0) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Sofosbuvir (CAS 1190307-88-0) Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Sofosbuvir (CAS 1190307-88-0) Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Sofosbuvir (CAS 1190307-88-0) Consumption Forecast by Type (2022-2027)
15.3.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue Forecast by Type (2022-2027)
15.3.3 Global Sofosbuvir (CAS 1190307-88-0) Price Forecast by Type (2022-2027)
15.4 Global Sofosbuvir (CAS 1190307-88-0) Consumption Volume Forecast by Application (2022-2027)
15.5 Sofosbuvir (CAS 1190307-88-0) Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
Request Sample 
Request Discount 
Inquire Before Buy
